Wong Florence
Division of Gastroenterology, Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ont., Canada.
Dig Dis. 2015;33(4):539-47. doi: 10.1159/000375345. Epub 2015 Jul 6.
Acute kidney injury (AKI) is a common complication of advanced cirrhosis. Type 1 hepatorenal syndrome is the best-known and most severe form of AKI, and it has a precise definition and a set of specific diagnostic criteria. More recently, it has become recognized that milder degrees of renal dysfunction also have a negative impact on patient outcome in various patient populations. Key Messages: Several definitions and criteria for staging the severity of AKI have been proposed, including the RIFLE (Risk, Injury, Failure, Loss of Function and End-Stage Renal Disease) group, the Acute Kidney Injury Network (AKIN), and the Kidney Disease: Improving Global Outcome (KDIGO) group. All of them incorporate some changes of serum creatinine and urine output in the definition and staging of AKI. The hepatology community has mostly embraced the AKIN diagnostic and staging criteria and has applied them in the prognostication of patients with advanced cirrhosis. However, the AKIN criteria have not been strictly applied in all studies on cirrhosis. This is partly related to the fact that changes in urine output are difficult to assess in advanced cirrhosis, and partly related to the difficulty in defining the baseline serum creatinine from which the change in serum creatinine is calculated. This has led to some confusion in the interpretation of results of the various studies on AKI in cirrhosis. More recently, some investigators have suggested incorporating the AKIN criteria with setting a lower limit of serum creatinine of 1.5 mg/dl in determining the diagnosis and prognosis of AKI in cirrhosis.
This is an ongoing debate as to how best to define AKI in cirrhosis. In the near future there should be prospective clinical trials that will clarify which diagnostic and staging criteria of AKI will best serve the cirrhotic population.
急性肾损伤(AKI)是晚期肝硬化常见的并发症。1型肝肾综合征是最广为人知且最严重的AKI形式,它有精确的定义和一套特定的诊断标准。最近,人们已经认识到,较轻程度的肾功能不全对不同患者群体的预后也有负面影响。关键信息:已经提出了几种AKI严重程度分期的定义和标准,包括RIFLE(风险、损伤、衰竭、功能丧失和终末期肾病)组、急性肾损伤网络(AKIN)以及改善全球肾脏病预后组织(KDIGO)。它们在AKI的定义和分期中均纳入了血清肌酐和尿量的一些变化。肝病学界大多采用AKIN诊断和分期标准,并将其应用于晚期肝硬化患者的预后评估。然而,并非所有关于肝硬化的研究都严格应用了AKIN标准。这部分是因为在晚期肝硬化中尿量变化难以评估,部分是因为难以确定用于计算血清肌酐变化的基线血清肌酐。这导致了对各种肝硬化AKI研究结果解释上的一些混乱。最近,一些研究人员建议在确定肝硬化AKI的诊断和预后时,将AKIN标准与设定血清肌酐下限1.5mg/dl相结合。
关于如何最好地定义肝硬化中的AKI,这一争论仍在继续。在不久的将来,应该会有前瞻性临床试验来阐明哪种AKI诊断和分期标准最适合肝硬化患者群体。